Poland· PL-100514962
Vimkunya
A medicinal product containing szczepionka przeciw chikungunya (rekombinowana, adsorbowana), registered in Poland by Bavarian Nordic A/S.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw Chikungunya (rekombinowana, adsorbowana)
- Manufacturer
- Bavarian Nordic A/S
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05715036001475
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b72d3e45-b5df-4974-9e81-52bbe2186dbe GET /v1/drugs/b72d3e45-b5df-4974-9e81-52bbe2186dbe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "1 dawka (0,8 ml)",
"packaging": "05715036001475 ¦ Rp ¦ EU/1/25/1916/001 ¦ 160975\n1 amp.-strzyk. 0,8 ml\n¦ UR/Z/4c/143/26 - 05715036001475",
"substance": "Szczepionka przeciw Chikungunya (rekombinowana, adsorbowana) 1 dawka (0,8 ml)",
"common_name": "Szczepionka przeciw Chikungunya (rekombinowana, adsorbowana)",
"pl_product_id": "100514962",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about szczepionka przeciw chikungunya (rekombinowana, adsorbowana).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.